Cyclic nucleotide phosphodiesterase 1C promotes human arterial smooth muscle cell proliferation.
about
Lung vasodilatory response to inhaled iloprost in experimental pulmonary hypertension: amplification by different type phosphodiesterase inhibitors.DNA Damage: A Main Determinant of Vascular AgingCardiac cAMP: production, hydrolysis, modulation and detectionRegulation of phosphodiesterase 3 and inducible cAMP early repressor in the heartRole of nuclear Ca2+/calmodulin-stimulated phosphodiesterase 1A in vascular smooth muscle cell growth and survivalInhibitory effects of vinpocetine on the progression of atherosclerosis are mediated by Akt/NF-κB dependent mechanisms in apoE-/- miceAnti-atherogenic properties of resveratrol: 4-week resveratrol administration associated with serum concentrations of SIRT1, adiponectin, S100A8/A9 and VSMCs contractility in a rat model.Inhibition of phosphodiesterase-1 attenuates cold-induced pulmonary hypertensionConcerted regulation of cGMP and cAMP phosphodiesterases in early cardiac hypertrophy induced by angiotensin IICardiac cyclic nucleotide phosphodiesterases: function, regulation, and therapeutic prospects.Cyclic nucleotide phosphodiesterase 1 regulates lysosome-dependent type I collagen protein degradation in vascular smooth muscle cellsTargeting cyclic nucleotide phosphodiesterase in the heart: therapeutic implications.Sustained entry of Ca2+ is required to activate Ca2+-calmodulin-dependent phosphodiesterase 1A.Decreased cGMP level contributes to increased contraction in arteries from hypertensive rats: role of phosphodiesterase 1New perspectives for the treatment of pulmonary hypertensionABCD of the phosphodiesterase family: interaction and differential activity in COPDCyclic nucleotide phosphodiesterase 1 and vascular agingSelective inhibition of phosphodiesterase 1 relaxes urinary bladder smooth muscle: role for ryanodine receptor-mediated BK channel activation.Role of cAMP-phosphodiesterase 1C signaling in regulating growth factor receptor stability, vascular smooth muscle cell growth, migration, and neointimal hyperplasia.Expression, activity, and function of phosphodiesterases in the mature and immature ductus arteriosus.BK channel regulation by phosphodiesterase type 1: a novel signaling pathway controlling human detrusor smooth muscle function.Calcium-dependent phosphodiesterase 1C inhibits renin release from isolated juxtaglomerular cells.Clinical and molecular genetics of the phosphodiesterases (PDEs).BK channel-mediated relaxation of urinary bladder smooth muscle: a novel paradigm for phosphodiesterase type 4 regulation of bladder function.Controversies and future perspectives of antiplatelet therapy in secondary stroke preventionPDE1 isozymes, key regulators of pathological vascular remodelingCyclic nucleotide phosphodiesterase (PDE) isozymes as targets of the intracellular signalling network: benefits of PDE inhibitors in various diseases and perspectives for future therapeutic developments.Phosphodiesterases and cyclic GMP regulation in heart muscle.Compartmentation of cAMP signalling in cardiomyocytes in health and disease.Phosphodiesterase-1 Inhibitory Activity of Two Flavonoids Isolated from Pistacia integerrima J. L. Stewart Galls.Characterization of inhibitors of phosphodiesterase 1C on a human cellular system.Generation and phenotypic characterization of Pde1a mutant mice.Ca2+/calmodulin-stimulated PDE1 regulates the beta-catenin/TCF signaling through PP2A B56 gamma subunit in proliferating vascular smooth muscle cellsExpression and activity of cAMP phosphodiesterase isoforms in pulmonary artery smooth muscle cells from patients with pulmonary hypertension: role for PDE1.Antiproliferative effects of phosphodiesterase type 5 inhibition in human pulmonary artery cells.Phosphodiesterase type 5 and cancers: progress and challenges.Phosphodiesterase-1b (Pde1b) knockout mice are resistant to forced swim and tail suspension induced immobility and show upregulation of Pde10a.PDE1A inhibition elicits cGMP-dependent relaxation of rat mesenteric arteries.Cyclic nucleotide phosphodiesterase-1C (PDE1C) drives cell proliferation, migration and invasion in glioblastoma multiforme cells in vitro.Novel selective PDE type 1 inhibitors cause vasodilatation and lower blood pressure in rats.
P2860
Q24815216-107B507E-5C1F-47AD-AC08-553931792994Q26746962-3A053A6E-A83A-464D-A475-4804CC730AE4Q26781612-F5C24CB7-ACA8-4289-B508-FD52DACFDEE1Q28291007-51333489-3FB9-4498-A197-0026ECFC02A8Q28568576-899049B8-AA3B-4531-99EF-4F682AE920B1Q31146253-BD45FE97-DA2E-4BC6-8931-2D1A60851E9FQ33724276-9F656C9C-A787-4281-B8AB-7799A8D9DB56Q33729763-AF2AFBD0-81F0-4F7F-850E-8A26F9704E96Q33769656-086A153A-8485-4301-9F0F-36D36C5BA2B9Q33966155-655A065C-062C-4D00-886F-92018E06942EQ33966213-F582ECDC-171B-415A-81FA-89A05DF907E7Q34252901-BEA6EA46-8C54-4C5A-9559-7748CD102159Q34335537-9352F8B0-2D5F-4298-89BF-7B8E8F7B4082Q34780141-F6733EB0-51F0-4B95-92C1-27E81071C41EQ34903204-CFC0F77D-D938-450A-A7C6-88F0C7BBAA31Q34961511-909B529D-92A1-4505-A3E0-778AAF675BA5Q36175455-859C919F-5440-4576-A8CC-4B5E3A400D55Q36382456-C2D292A5-3849-437D-8348-BC5BF93837E2Q36433005-C2BDEEF5-BA80-4B17-95F7-9D9B4D0F565FQ37037036-7761C3CE-5A39-40DB-831C-A48790A3123DQ37211818-C9E6BA52-B194-4E2A-A29A-1FC3FD8BCB9BQ37422056-4604D909-F8DB-459E-8B3B-088A35176CE5Q37657841-B3E9E040-7BBC-4089-9B5D-5ABD041B9970Q37663366-B3AB88D7-ED22-4E61-916A-DAC235EB22E8Q37782412-27CF84E6-69C1-486D-8024-5B616E66BC13Q37941150-06C8B074-1418-451B-BB6A-F5D6A5C3131EQ37947681-2AF38078-7A0D-444F-8D3D-E1E3E96CD45EQ38033089-309AB8DC-AAE9-4165-B418-B10AF6EA034AQ38079253-455EC909-0E76-43E5-A6C0-53D9430FF9E6Q39763098-EE18FCD8-6335-4057-9631-631958D698FDQ40094557-7958A56C-D710-4377-8590-245E8EBF9661Q41153428-E6BAF6AA-C08F-4AFF-AACA-B2CE93B25253Q42176198-81527604-5FC5-48C7-8C16-4028D35BEDECQ44852804-0D6F0539-BB4E-43B3-9B56-A1D522681493Q46427835-8464C7BB-BDF0-4F74-BC82-0C1C82186517Q47171803-41D1BBA5-3F43-4BA5-84CB-6C46AE976B6CQ47936368-B7897299-E42C-4407-AFBC-ECC73AEECE4DQ48345105-938776B6-B566-4D9B-940C-D20A46529839Q48360844-FAA17761-3E79-4140-9272-B236016E6B0FQ48370513-BCE5460F-88A0-473B-97BE-1D64ADE1E705
P2860
Cyclic nucleotide phosphodiesterase 1C promotes human arterial smooth muscle cell proliferation.
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Cyclic nucleotide phosphodiest ...... oth muscle cell proliferation.
@ast
Cyclic nucleotide phosphodiest ...... oth muscle cell proliferation.
@en
Cyclic nucleotide phosphodiest ...... oth muscle cell proliferation.
@nl
type
label
Cyclic nucleotide phosphodiest ...... oth muscle cell proliferation.
@ast
Cyclic nucleotide phosphodiest ...... oth muscle cell proliferation.
@en
Cyclic nucleotide phosphodiest ...... oth muscle cell proliferation.
@nl
prefLabel
Cyclic nucleotide phosphodiest ...... oth muscle cell proliferation.
@ast
Cyclic nucleotide phosphodiest ...... oth muscle cell proliferation.
@en
Cyclic nucleotide phosphodiest ...... oth muscle cell proliferation.
@nl
P2093
P356
P1433
P1476
Cyclic nucleotide phosphodiest ...... oth muscle cell proliferation.
@en
P2093
Irina Rybalkina
Joseph A Beavo
Karin E Bornfeldt
Sergei D Rybalkin
P304
P356
10.1161/HH0202.104108
P577
2002-02-01T00:00:00Z